JPMorgan Chase & Co (XKAZ:JPM_KZ)
$ 242.3 1.38 (0.56%) Market Cap: 685.62 Bil Enterprise Value: 733.80 Bil PE Ratio: 13.55 PB Ratio: 2.11 GF Score: 44/100

Veradigm Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 11:15 AM Transcript

Jan 10, 2024 / 07:15PM GMT
Release Date Price: $170.65
Anne Elizabeth Samuel
JPMorgan Chase & Co, Research Division - Analyst

Good morning, everyone. Welcome to day 3 of the JPMorgan Healthcare Conference. My name is Annie Samuel and I'm the health care technology and distribution analyst here at JPMorgan. We're really excited to have Veradigm here with us this morning. With us are interim CEO, Dr. Yin Ho; and Interim CFO, Lee Westerfield. And we're also going to be joined by the CEO of ScienceIO, Will Manidis for a conversation about AI. So with that, let me turn it over to Dr. Ho.

Shih;Yin Ho
Veradigm Inc. - Interim CEO & Director

Well, good morning, everyone. Thank you for joining us in person and via webcast. I'm Dr. Yin Ho. I'm the CEO of Veradigm, and it is truly a pleasure to be here today. Thank you, Annie, for giving us the opportunity to introduce ourselves. We really look forward to beginning a dialogue with all of you about our company, Veradigm, and the opportunities we have to shape the future of health care.

This presentation contains forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot